We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




RTS Life Sciences to Produce Robotic Blood System

By HospiMedica staff writers
Posted on 17 Apr 2006
Print article
RTS Life Sciences (Manchester, UK) has won a contract to design and install an automated robotic system incorporating machine vision for the new UK Biobank (Cheadle, UK).

The contract follows the development of a prototype vision system by the company. The full fractionation system will be commissioned in the second quarter of 2006, by which time it will be fully integrated with Biobank's software and database.

The UK Biobank aims to build a major resource to support research that will improve the prevention, diagnosis, and treatment of illness and promote health throughout society. The project will follow the health of 500,000 volunteers for up to 30 years, collecting information on environment and lifestyle factors, and linking these to medical records and biologic samples.

Paul Downey, director of laboratory operations at the UK Biobank, explained that the research would require approximately 3,500 samples of blood to be processed each day. In addition to the large number of technicians this output would require, there are the serious health aspects of exposing people to such large amounts of unscreened blood.

When blood is centrifuged at low speeds, it separates into three fractions: plasma, the buffy coat containing the white blood cells, and erythrocytes. The RTS system centrifuges the blood into individual containers, identifies each sample, identifies the fractions, and aliquots the chosen fraction into arrays of 96 x1 ml tubes. A digital camera takes two images and software analyzes the images to determine the exact boundaries between the layers. The layers are then converted into liquid handling protocols and mapped to destination tubes before the robot aliquots the layers into tubes prior to storage or preparation for assays.

The UK Biobank will collect and store all fractions of blood as each fraction can reveal something different about an individual's health, and because more detailed assays will be developed in the future.



Related Links:
RTS Life Sciences
UK Biobank
New
Gold Member
Syphilis Screening Test
VDRL Antigen MR
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Silver Member
Oncology Molecular Diagnostic Test
BCR-ABL Dx ELITe MGB Kit
New
Silver Member
Apolipoprotein A-I Assay
Apo A-I Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.